Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia
Launched by AIN SHAMS UNIVERSITY · Mar 29, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether two supplements, Coenzyme Q10 and L-Carnitine, can help improve semen quality in men who are having trouble fathering a child. The specific condition being addressed is called idiopathic oligosasthenoteratospermia, which means the semen has low numbers of sperm, poor movement, and abnormal shapes, but the cause is not known. The researchers are currently looking for male participants who have been experiencing infertility for at least a year without using contraception.
To be eligible for this study, men must not have any active genital infections or problems with ejaculation, and they should not be completely without sperm (a condition called azoospermia). If you choose to participate, you will receive the supplements and be monitored for changes in your semen quality over the course of the trial. This study aims to provide valuable information that could help men facing similar infertility challenges in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • of in¬fertility of 1 year or more without the use of contraception
- Exclusion Criteria:
- • o Active genital infections.
- • Patients with ejaculatory dysfunction
- • Azoospermia
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported